CRVAF.US CurveBeam AI Limited

Healthcare Medical Devices USA Stocks
0.0540 USD
Close of Nov 14, 2026
0.0540 0.0540
Market cap
USD 20.9M
P/E
-
P/B
0.92x
ROE
-67.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is CRVAF.US undervalued?

Graham number

The Graham number of CurveBeam AI Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CurveBeam AI Limited fundamental analysis

No fundamental analysis for CurveBeam AI Limited yet.

CurveBeam AI Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CurveBeam AI Limited

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the …

Full company profile